Show simple item record

dc.contributor.authorKandadai, Padma
dc.contributor.authorPatterson, Danielle
dc.contributor.authorO'Dell, Katherine K.
dc.contributor.authorSaini, Jyot
dc.contributor.authorFlynn, Michael
dc.date2022-08-11T08:10:06.000
dc.date.accessioned2022-08-23T16:55:48Z
dc.date.available2022-08-23T16:55:48Z
dc.date.issued2015-09-01
dc.date.submitted2017-08-11
dc.identifier.citationFemale Pelvic Med Reconstr Surg. 2015 Sep-Oct;21(5):257-62. doi: 10.1097/SPV.0000000000000151. <a href="https://doi.org/10.1097/SPV.0000000000000151">Link to article on publisher's site</a>
dc.identifier.issn2151-8378 (Linking)
dc.identifier.doi10.1097/SPV.0000000000000151
dc.identifier.pmid25521470
dc.identifier.urihttp://hdl.handle.net/20.500.14038/42789
dc.description.abstractOBJECTIVE: This study aimed to determine risk factors, including postoperative analgesic use, for the development of postoperative urinary retention (PUR) after hysterectomy for routine gynecologic indications using a case-control study design. METHODS: Cases of PUR after hysterectomy were identified from billing data. Cases were those patients requiring recatheterization for inability to void. Controls were similarly identified and matched by age and date of surgery in a 3:1 control-to-case ratio. Chart review was performed to obtain demographic, medical, surgical, anesthetic, and medication data. Cumulative and interval doses of postoperative narcotic were recorded and converted into morphine equivalents. Crude odds ratios (ORs) were determined for potential risk factors for PUR using standard statistical analysis. Conditional logistic regression was used on multivariate models, including cumulative postoperative narcotic use, to determine adjusted ORs for risk factors. RESULTS: Twenty-six cases of PUR were matched with 78 controls. The cases had a higher body mass index (32 vs 28 kg/m2, P = 0.02), had a higher preoperative use of tricyclic antidepressants (TCA; 19.2% vs 1.3%, P = 0.004), were more likely to present preoperative urinary retention associated with fibroids (19.2% vs 0%, P < 0.01), and received a higher cumulative narcotic dose in the postoperative period (109 vs 73.6 mg, P < 0.001). In a multivariate model, preoperative TCA use (OR, 30.1; 95% confidence interval, 1.99-456; P = 0.01) and cumulative narcotic dose (OR, 2.54; 95% confidence interval, 1.44-4.56; P < 0.01) were significantly associated with PUR. CONCLUSIONS: Postoperative urinary retention after hysterectomy is associated with higher postoperative narcotic dose, preoperative TCA use, and preoperative urinary retention.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=25521470&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttps://doi.org/10.1097/SPV.0000000000000151
dc.subjectFemale Urogenital Diseases and Pregnancy Complications
dc.subjectMaternal and Child Health
dc.subjectObstetrics and Gynecology
dc.subjectWomen's Health
dc.titleUrinary Retention After Hysterectomy and Postoperative Analgesic Use
dc.typeJournal Article
dc.source.journaltitleFemale pelvic medicine and reconstructive surgery
dc.source.volume21
dc.source.issue5
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/obgyn_pp/144
dc.identifier.contextkey10586768
html.description.abstract<p>OBJECTIVE: This study aimed to determine risk factors, including postoperative analgesic use, for the development of postoperative urinary retention (PUR) after hysterectomy for routine gynecologic indications using a case-control study design.</p> <p>METHODS: Cases of PUR after hysterectomy were identified from billing data. Cases were those patients requiring recatheterization for inability to void. Controls were similarly identified and matched by age and date of surgery in a 3:1 control-to-case ratio. Chart review was performed to obtain demographic, medical, surgical, anesthetic, and medication data. Cumulative and interval doses of postoperative narcotic were recorded and converted into morphine equivalents. Crude odds ratios (ORs) were determined for potential risk factors for PUR using standard statistical analysis. Conditional logistic regression was used on multivariate models, including cumulative postoperative narcotic use, to determine adjusted ORs for risk factors.</p> <p>RESULTS: Twenty-six cases of PUR were matched with 78 controls. The cases had a higher body mass index (32 vs 28 kg/m2, P = 0.02), had a higher preoperative use of tricyclic antidepressants (TCA; 19.2% vs 1.3%, P = 0.004), were more likely to present preoperative urinary retention associated with fibroids (19.2% vs 0%, P < 0.01), and received a higher cumulative narcotic dose in the postoperative period (109 vs 73.6 mg, P < 0.001). In a multivariate model, preoperative TCA use (OR, 30.1; 95% confidence interval, 1.99-456; P = 0.01) and cumulative narcotic dose (OR, 2.54; 95% confidence interval, 1.44-4.56; P < 0.01) were significantly associated with PUR.</p> <p>CONCLUSIONS: Postoperative urinary retention after hysterectomy is associated with higher postoperative narcotic dose, preoperative TCA use, and preoperative urinary retention.</p>
dc.identifier.submissionpathobgyn_pp/144
dc.contributor.departmentDepartment of Obstetrics and Gynecology, Division of Urogynecology and Reconstructive Pelvic Surgery
dc.source.pages257-62


This item appears in the following Collection(s)

Show simple item record